Testing effectiveness (Phase 2)Study completedNCT01977755
What this trial is testing
Phase 2 Clinical Proof-of-Concept Study of the Cardioprotective Properties of Danegaptide in ST Segment Elevation Myocardial Infarction
Who this might be right for
Focus of Study is STEMI
Zealand Pharma 591